|
Pharmacological Group: Antineoplastics, Active Ingredient: Dacarbazine, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration/Dosage: 200, Unit: Mg, Volume: Not Applicable, Presentation: Ampoule Vial, Accessory: Not Applicable, Active Ingredient: Oxaliplatin, Concentration/Dosage: 100, Active Ingredient: Paclitaxel, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 6, Unit: Mg/Ml, Volume: 5Ml, Active Ingredient: Trastuzumab, Concentration / Dosage: 440, Accessory: Diluent, Active Ingredient: Letrozole, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 2, 5, Presentation: Not Applicable, Volume: 16, 7Ml, Accessory: N/A, Active Ingredient: Regorafenib, Pharmaceutical Form: Tablet, Concentration / Dosage: 40, Volume: N/A, Presentation: N/A, Active Ingredient: Pertuzumab, Concentration / Dosage: 30, Volume: 14, Presentation: Ampoule Bottle, Supply Form: Unit, Active Ingredient: Trastuzumab Emtansine, Concentration / Dosage: 20, Pharmacological Group: Antineoplastic/Antimemetabolic, Active Ingredient: Pegylated Liposomal Doxorubicin, Pharmaceutical Form: Injectable Suspension, Volume: 10 Ml, Accessory: Na, Concentration / Dosage: 50, Pharmacological Group: Antineoplastic, Active Ingredient: Olaparib, Concentration/Dosage: 150, Pharmacological Group: Antineoplastics/Hormones, Enzyme And Hormonal Action Inhibitors, Active Ingredient: Ribociclib, Presentation: Tablet
|
